• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

The mechanism of carcinogenesis in ovarian clear cell carcinoma and ovarian endometrioid carcinoma from endometriosis.

Research Project

  • PDF
Project/Area Number 19791168
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Obstetrics and gynecology
Research InstitutionKeio University (2008-2009)
Showa University (2007)

Principal Investigator

AKAHANE Tomoko  Keio University, 医学部, 研究員 (40398699)

Project Period (FY) 2007 – 2009
Keywords卵巣癌 / 卵巣卵巣明細胞腺癌 / 卵巣類内膜腺癌 / 子宮内膜症 / 悪性メカニズム
Research Abstract

The origin of ovarian clear cell carcinoma and ovarian endometrioid caricinoma has been speculated to derive from endometriosis. In this research, we revealed the mechanism of carcinogenesis of ovarian clear cell carcinoma and ovarian endometrioid carcinoma from endometriosis. We analyzed both p53 gene mutation using DNA extracted from pathological section of ovarian clear cell carcinoma and ovarian endometrioid carcinoma with endometriosis obtained by Laser Microdissection method, and the allele frequency of the amino acid variation (c.215 G>C Arg72Pro) of the p53 gene codon72 using ovarian cancer patient's genomic DNA. We found that p53 gene mutation was detected in ovarian clear cell carcinoma with endometriosis cells and not in ovarian endometrioid carcinoma of endometriosis, and Pro/Pro allele frequency increased in ovarian cancer patients(P<0.003). These results suggested that the factor p53 gene mutation is related in the specialization of different pathological types and that p53 codon72 Pro/Pro allele is a risk factor of ovarian cancer.

  • Research Products

    (19 results)

All 2010 2009 2008 2007 Other

All Journal Article (3 results) (of which Peer Reviewed: 3 results) Presentation (13 results) Remarks (1 results) Patent(Industrial Property Rights) (2 results)

  • [Journal Article] Protein kinase C δ and η differently regulate the expression of loricrin and Jun family proteins in human keratinocytes.2010

    • Author(s)
      Nagisa Kamioka, Tomoko Akahane, Motoi Ohba, et al
    • Journal Title

      Biochemical and Biophysical Research Communications (in press)

    • Peer Reviewed
  • [Journal Article] ヒト三次元培養皮膚への遺伝子導入法の確立と表皮分化へのCキナーゼの関与2010

    • Author(s)
      上岡なぎさ、赤羽智子、大場基, 他3名
    • Journal Title

      昭和医学会誌 (in press)

    • Peer Reviewed
  • [Journal Article] The role of P53 mutation in the carcinogenesis from endometriosis.2007

    • Author(s)
      Akahane T, Sekizawa A, Purwosunu Y, Nagatsuka M, Okai T.
    • Journal Title

      Int J Gynecol Pathol 26

      Pages: 345-351

    • Peer Reviewed
  • [Presentation] Association between the UGT1A1 polymorphism, bilirubin levels, and dyslipidemia in endometrial cancer.2010

    • Author(s)
      Matsumura S, Hirasawa A, Akahane T, et al
    • Organizer
      AACR/JCA Joint Conference
    • Place of Presentation
      Hawaii, USA
    • Year and Date
      20100205-20100209
  • [Presentation] Association between the UGT1A1 polymorphism, dyslipidemiaand endometrial cancer.2010

    • Author(s)
      Hirasawa A, Akahane T, Matsumura S, et al
    • Organizer
      AACR/JCA Joint Conference
    • Place of Presentation
      Hawaii, USA
    • Year and Date
      20100205-20100209
  • [Presentation] ファーマコゲノミクスの臨床応用を目指した新規遺伝子多型診断システムの確立2009

    • Author(s)
      平沢晃、松村聡子、鶴田智彦、赤羽智子, 他6名
    • Organizer
      第30回日本臨床薬理学会年会
    • Place of Presentation
      横浜
    • Year and Date
      20091203-20091205
  • [Presentation] Analysis of UGT1A1 polymorphism and serum bilirubin levels for individualized cancer therapy using irinotecan.2009

    • Author(s)
      Hirasawa A, Akahane T, Tsuruta T, et al
    • Organizer
      The 4th Asian Confernce on Pharmacoepidemiology
    • Place of Presentation
      Tainan, Taiwan
    • Year and Date
      20091023-20091025
  • [Presentation] Effects of UGT1A1 polymorphism on irinotecan-induced drug reaction and serum bilirubin levels.2009

    • Author(s)
      Hirasawa A, Akahane T, Tsuruta T, et al
    • Organizer
      The 59th Annual Meeting of The American Society of Human Genetics
    • Place of Presentation
      Hawaii, USA
    • Year and Date
      20091020-20091024
  • [Presentation] 子宮体癌における腹腔細胞診の臨床的意義と新規診断マーカーの検索2009

    • Author(s)
      冨永英一郎、進伸幸、赤羽智子, 他4名
    • Organizer
      第50回日本組織細胞化学会総会
    • Place of Presentation
      滋賀
    • Year and Date
      20090926-20090927
  • [Presentation] UGT1A1遺伝子多型と血清ビリルビン値およびイリノテカンの有害事象に関するゲノム薬理学的検討2009

    • Author(s)
      平沢晃、赤羽智子、鶴田智彦, 他5名
    • Organizer
      第54回日本人類遺伝学会
    • Place of Presentation
      東京
    • Year and Date
      20090924-20090926
  • [Presentation] Pharmacogenomic effects of UDPglucuronosyltransferase1A1 on irinotecan -induced drug reaction and serum biliru bin levels.2009

    • Author(s)
      Hirasawa A, Akahane T, Tsuruta T, et al
    • Organizer
      2009 European Human Genet ics Conference
    • Place of Presentation
      Vienna, Austria
    • Year and Date
      20090523-20090526
  • [Presentation] 子宮体がんにおけるマイクロRNAの発現プロファイリング2009

    • Author(s)
      平沢晃、齋藤康一郎、赤羽智子, 他6名
    • Organizer
      第46回日本婦人科腫瘍学会学術集会
    • Place of Presentation
      新潟
    • Year and Date
      2009-07-10
  • [Presentation] アレイCGHによる子宮体癌関連遺伝子および薬剤感受性遺伝子の探索(ワークショップ)2009

    • Author(s)
      鶴田智彦、平沢晃、赤羽智子, 他6名
    • Organizer
      第50回日本臨床細胞学会総会
    • Place of Presentation
      東京
    • Year and Date
      2009-06-27
  • [Presentation] 子宮体癌腹腔細胞診の臨床的意義(シンポジウム)2009

    • Author(s)
      冨永英一郎、進伸幸、平沢晃、赤羽智子, 他3名
    • Organizer
      第50回日本臨床細胞学会総会
    • Place of Presentation
      東京
    • Year and Date
      2009-06-27
  • [Presentation] UGT1A1遺伝子多型と血清ビリルビン値の関連および婦人科イリノテカン療法副作用への関与に関する検討2008

    • Author(s)
      平沢晃、赤羽智子, 他10名
    • Organizer
      第29回日本臨床薬理学会
    • Place of Presentation
      東京
    • Year and Date
      2008-12-13
  • [Presentation] UGT1A1遺伝子多型と血清ビリルビン値の関連および婦人科イリノテカン療法副作用への関与に関する検討2008

    • Author(s)
      平沢晃、赤羽智子, 他10名
    • Organizer
      第67回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-29
  • [Remarks]

    • URL

      http://k-ris.keio.ac.jp/Profiles/0150/0017635/profile.html

  • [Patent(Industrial Property Rights)] バイオマーカーとしてのマイクロRNAを用いた婦人科がんの診断・治療選択2008

    • Inventor(s)
      座間猛 平沢晃齋藤康一郎赤羽智子
    • Industrial Property Rights Holder
      座間猛 平沢晃齋藤康一郎赤羽智子
    • Industrial Property Number
      特許・2008-310487
    • Filing Date
      2008-12-04
  • [Patent(Industrial Property Rights)] バイオマーカーとしてのマイクロRNAを用いた婦人科がんの診断・治療選択2008

    • Inventor(s)
      座間猛平沢晃齋藤康一郎赤羽智子
    • Industrial Property Rights Holder
      座間猛平沢晃齋藤康一郎赤羽智子
    • Industrial Property Number
      特許・2008-310487
    • Acquisition Date
      2008-12-24

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi